Articles

Cancer treatment already costs hundreds of thousands of dollars — and it’s about to get even worse

Someone who survived brain cancer in the 1990s explains how the Affordable Care Act could have helped.

Micron investors are partying like it’s 1987, and the stock still looks pretty cheap

Shares of Micron were headed for their best monthly performance since 1987, but analysts still see them as a value play.

This mutual fund lets you buy SpaceX stock before the IPO — but what are you actually getting?

The hype surrounding SpaceX and the scale of its ambitions will surely drive short-term demand for shares in the IPO.

This stock-market strategy is a smart way to play Micron and the memory-chip rally

Adding a value component and trimming back on the hottest growth stocks has served this growth ETF well over the long term and during the AI build-out.

Is Microsoft ditching OpenAI for Anthropic?

A recent Anthropic partnership could provide a $43 billion revenue opportunity for Microsoft Azure by 2030, according to HSBC

In America, Big Tech’s AI data centers come first — and your community will be last to know

An unexpected power crisis facing 49,000 California households could be just one of many as tech giants monopolize local electricity.

Why this fund manager who was an early proponent of Nvidia is now betting on AI’s space frontier

T. Rowe Price’s Tony Wang is looking AI for bottlenecks and finding them, and also sees returns in space and light.

Why America is losing the AI productivity war to 3.5 million Chinese STEM graduates

Big Tech’s structural mistakes are costing stock investors and fueling a massive talent crisis.

OpenAI’s biggest problem isn’t AI safety. It’s Sam Altman.

‘Conflict-averse’ CEO has built a culture of groupthink — and a massive corporate liability,

China’s next export shock walks on two legs — and costs less than a used car

Beijing is funding humanoid robots to slash Chinese factory costs and build a competitive advantage.

The market isn’t fully pricing in a U.S.-Iran peace deal — and that could be just the lift European stocks need

Since the start of the war in Iran, investors have favored U.S. stocks over international equities, but a deal could help to reduce the gap.

‘I’m unsure of the best approach’: My father, 91, is in hospice care. He left his six children CDs. Can we cash out?

“His banker suggested that it might be easier after my father’s passing if we liquidate all of the CDs.”
1 79 80 81 82 83 2,685